These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24940066)

  • 41. Cost benefit analysis of clinical pharmacist interventions in medical intensive care unit in Palestine medical complex: Prospective interventional study.
    Houso A; Hamdan M; Falana H
    Saudi Pharm J; 2022 Dec; 30(12):1718-1724. PubMed ID: 36601501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of Daily Fluid Balance prior to Continuous Renal Replacement Therapy on Outcomes in Critically Ill Patients.
    Han MJ; Park KH; Shin JH; Kim SH
    J Korean Med Sci; 2016 Aug; 31(8):1337-44. PubMed ID: 27478348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug dosing during continuous renal replacement therapies.
    Thompson AJ
    J Pediatr Pharmacol Ther; 2008 Apr; 13(2):99-113. PubMed ID: 23055873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand.
    Sukkha S; Rattanavipanon W; Chamroenwit B; Sanganurak M; Nathisuwan S; Chaikledkaew U; Kongwatcharapong J
    Int J Clin Pharm; 2020 Apr; 42(2):610-616. PubMed ID: 32221826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of specialized continuous renal replacement therapy team in acute kidney injury patients treatment.
    Kee YK; Kim EJ; Park KS; Han SG; Han IM; Yoon CY; Lee E; Joo YS; Kim DY; Lee MJ; Park JT; Han SH; Yoo TH; Kim BS; Kang SW; Choi KH; Oh HJ
    Yonsei Med J; 2015 May; 56(3):658-65. PubMed ID: 25837170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of circuit patency and exchange rates between 2 different continuous renal replacement therapy machines.
    Razavi SA; Still MD; White SJ; Buchman TG; Connor MJ
    J Crit Care; 2014 Apr; 29(2):272-7. PubMed ID: 24360820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous Renal Replacement Therapy (CRRT) in Children and the Specialized CRRT Team: A 14-Year Single-Center Study.
    Lee KH; Sol IS; Park JT; Kim JH; Shin JW; Park MR; Lee JH; Kim YH; Kim KW; Shin JI
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31906191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Relationship between the timing of initiation of continuous renal replacement therapy and the prognosis of patients with sepsis-associated acute kidney injury].
    Wu X; Ye J; Sun M; Wang Z; Chen Q; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1352-1355. PubMed ID: 33463496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy.
    Vaara S; Pettila V; Kaukonen KM
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):147-57. PubMed ID: 22092254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing.
    Muilwijk EW; de Lange DW; Schouten JA; Wasmann RE; Ter Heine R; Burger DM; Colbers A; Haas PJ; Verweij PE; Pickkers P; Brüggemann RJ
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32816723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Influence of time of initiation of continuous renal replacement therapy on prognosis of critically ill patients with acute kidney injury].
    Hu ZJ; Liu LX; Zhao CC
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jul; 25(7):415-9. PubMed ID: 23834940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
    Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
    Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effectiveness of a specialized team intervention on prognosis in patients undergoing continuous renal replacement therapy: A retrospective cohort study.
    Shimada H; Kataoka Y; Tsunemitsu T; Takeoka H
    Clin Nephrol; 2021 Feb; 95(2):87-92. PubMed ID: 33191901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review.
    Chen H; Yu RG; Yin NN; Zhou JX
    Crit Care; 2014 Dec; 18(6):675. PubMed ID: 25482187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A primer on continuous renal replacement therapy for critically ill patients.
    Joy MS; Matzke GR; Armstrong DK; Marx MA; Zarowitz BJ
    Ann Pharmacother; 1998 Mar; 32(3):362-75. PubMed ID: 9533067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill.
    Buckley MS; Knutson KD; Agarwal SK; Lansburg JM; Wicks LM; Saggar RC; Richards EC; Kopp BJ; Erstad BL
    Ann Pharmacother; 2020 Feb; 54(2):105-112. PubMed ID: 31544470
    [No Abstract]   [Full Text] [Related]  

  • 59. Low-dose continuous renal replacement therapy for acute kidney injury.
    Fujii T; Namba Y; Fujitani S; Sasaki J; Narihara K; Shibagaki Y; Uchino S; Taira Y
    Int J Artif Organs; 2012 Jul; 35(7):525-30. PubMed ID: 22661111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.
    Rech MA; Gurnani PK; Peppard WJ; Smetana KS; Van Berkel MA; Hammond DA; Flannery AH
    Crit Care Explor; 2021 Dec; 3(12):e0594. PubMed ID: 34913039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.